Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden)
- 1 September 1973
- journal article
- clinical trial
- Published by Springer Nature in Diabetologia
- Vol. 9 (1), 339-347
- https://doi.org/10.1007/bf01218444
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmacokinetics of glipizide in man: Influence of renal insufficiencyDiabetologia, 1973
- Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabeticDiabetologia, 1973
- Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjectsDiabetologia, 1973
- Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamideDiabetologia, 1973
- Insulinotropic potency of glipizide in vitroDiabetologia, 1973
- Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man—Comparison with GlibenclamideThe Journal of Clinical Pharmacology and New Drugs, 1973
- [Clinical experimentation with a new hypoglycemic agent (glipizide)].1972
- [Pharmacokinetics and metabolism of N-(4-( -(5-methylpyrazine-2-carboxyamido)-ethyl)-benzensulfonyl)-N'cyclohexylurea (K 4024) in experimental animals and in man].1972
- Over-all Therapeutic Usefulness of Glybenclamide, a New Hypoglycemic SulfonylureaDiabetes, 1970
- Clinical Evaluation of Drugs for the Treatment of DiabetesDiabetes, 1964